Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Daphne A. Stanley(National Institutes of Health), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Clement Asiedu(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Alfredo Nicosia(Ospedale Antonio Cardarelli), Stefano Colloca(RINA Consulting - Centro Sviluppo Materiali S.p.A. (Italy)), Annie W. Lau-Kilby(National Institutes of Health), Virginia Ammendola(Sigma Tau (Italy)), Fabiana Grazioli(Ceinge Biotecnologie Avanzate (Italy)), Antonella Folgori(Sigma Tau (Italy)), Kathryn E. Foulds, Joshua C. Johnson(National Institutes of Health), Lingshu Wang(National Institutes of Health), Gary J. Nabel(National Institutes of Health), Lisa E. Hensley(National Center for Emerging and Zoonotic Infectious Diseases), Mitzi M. Donaldson(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Adele Abbate, Mario Roederer(National Institutes of Health), Cheng Cheng(St. Jude Children's Research Hospital), John C. Trefry(United States Army Medical Research Institute of Infectious Diseases), Riccardo Cortese(Sigma Tau (Italy)), Anna N. Honko
Cited by 352
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k